Patent · US Active

PH20 polypeptide variants, formulations and uses thereof

US10865400B2 · kind B2 · utility

9Cited by

85References

18Claims

0Family size

Assignee

HALOZYME, INC. · US

Inventors

Ge Wei · San Diego, US
H. Michael Shepard · San Diego, US
Qiping Zhao · San Diego, US
Robert James Connor · Oceanside, US

Key dates

Filing date	Aug 2, 2016
Grant date	Dec 15, 2020
Priority date	—
Expiry date	Jul 25, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.